Labochema LT, UAB - financials and debts

Company age: 19 y. 5 mo.

Update

Labochema LT - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 5,711,474 5,885,054 6,122,483 4,932,092 5,448,410 6,162,614 5,286,855 6,863,062
Profit before tax 367,281 615,686 791,697 17,396 514,260 748,613 297,780 326,723
Net profit 353,398 602,693 720,205 12,111 495,928 723,703 294,125 320,258
Equity 1,368,773 1,705,810 1,836,015 1,848,126 2,344,054 2,367,757 2,161,882 2,232,140
Liabilities 1,622,993 893,711 1,673,780 627,205 1,395,308 1,344,240 879,976 785,080
Non-current assets 788,118 882,155 1,063,497 835,089 811,672 949,150 1,191,161 1,202,108
Current assets 2,191,568 1,711,030 2,438,094 1,633,511 2,926,804 2,749,596 1,839,228 1,798,391
Total assets 2,979,686 2,593,185 3,501,591 2,468,600 3,738,476 3,698,746 3,030,389 3,000,499
Taxes paid
STI taxes - - - - - 1,190,344 1,274,468 1,529,245
Social insurance contributions - - - - - 166,866 177,760 228,513
Financial indicators
Revenue change y/y +2.6% +3.0% +4.0% -19.4% +10.5% +13.1% -14.2% +29.8%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 11.9% 23.2% 20.6% 0.5% 13.3% 19.6% 9.7% 10.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 25.8% 35.3% 39.2% 0.7% 21.2% 30.6% 13.6% 14.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 6.2% 10.2% 11.8% 0.2% 9.1% 11.7% 5.6% 4.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 6.4% 10.5% 12.9% 0.4% 9.4% 12.1% 5.6% 4.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.2 0.5 0.9 0.3 0.6 0.6 0.4 0.4
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 170,917 218,640 286,992 219,204 251,465 267,940 215,790 267,392

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Consolidated Labochema LT finance

EUR
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 13,253,698 14,719,310 13,351,159 15,193,874
Profit before tax 521,609 913,733 155,664 418,463
Net profit 422,083 665,103 63,422 351,658
Equity 3,023,310 2,988,413 2,551,835 2,653,493
Liabilities 3,834,645 2,785,737 2,835,145 2,400,753
Non-current assets 448,255 514,633 802,021 810,957
Current assets 6,382,473 5,309,232 4,803,683 4,323,704
Total assets 6,830,728 5,823,865 5,605,704 5,134,661

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Labochema LT - Social security debts

From To Debt, €
2022-02-17 2022-02-20 0.30
2022-01-31 2022-02-08 0.30
2022-01-26 2022-01-30 0.27
2022-01-11 2022-01-12 0.27
2021-12-16 2021-12-29 0.01
2021-11-18 2021-12-08 0.01

Labochema LT - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Labochema LT, UAB (code 300670772) is a Private Limited Liability Company engaged in the wholesale of other chemical products. In 2025, the company generated revenue of €6.86M and net profit of €320.3K, with a profit margin of 4.7%. Revenue increased by 29.8% year on year in 2025, after declining from €6.16M in 2023 to €5.29M in 2024, showing a recovery in the latest year. Net profit followed a similar pattern, falling from €723.7K in 2023 to €294.1K in 2024, then improving slightly in 2025. At year-end 2025, total assets stood at €3.00M, equity at €2.23M and liabilities at €785.1K. The equity ratio was 74.4% and debt-to-equity stood at 0.35, indicating a solid balance sheet structure. Asset turnover was 2.29x, ROE was 14.3% and ROA was 10.7%. Revenue per employee reached €274.5K, while profit per employee was €12.8K, suggesting efficient sales productivity in 2025.